Graph Secures USD 3 Million Seed Funding from Bessemer for AI-Driven Drug Safety
California-based Graph AI has announced its USD 3 Million Seed round, led by Bessemer Venture Partners. The investment will enable Graph to accelerate product innovation, expand its engineering team, and drive global market adoption.
Regulatory Compliance | 17/10/2025 | By Dineshwori
India to Reform New Drugs and Clinical Trials Rules, Halve Processing Time for Test Licences
By amending the New Drugs and Clinical Trials (NDCT) Rules, 2019, the Indian government aims to simplify the requirements and procedures for obtaining test licences and for submitting applications related to Bioavailability/Bioequivalence (BA/BE) studies.
Regulatory Compliance | 04/09/2025 | By Dineshwori
While North America is projected to remain the largest market for pharmaceutical stability and storage services, the Asia-Pacific (APAC) region is expected to record the fastest CAGR during the forecast period.
Regulatory Compliance | 29/08/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy